http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105640897-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86f9fd708fb86712e0772b8311214e17
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
filingDate 2014-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c92e424f94d2cb19938d7722da06843f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0433f9d00caf75e90f8af560ea35f098
publicationDate 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105640897-A
titleOfInvention Ceftaroline fosamil pharmaceutical composition for injection
abstract The present invention relates to a stable and safe ceftaroline fosamil pharmaceutical composition for injection, and a preparation method thereof, preferably freeze-dried powder. According to the present invention, the ceftaroline fosamil pharmaceutical composition mainly comprises an active component ceftaroline fosamil, mannitol, and sodium hydroxide; and the obtained ceftaroline fosamil pharmaceutical composition for injection has characteristics of stable pH value, low impurity content, effectively-improved treatment effect, cost reducing, and high benefit creating.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106491537-A
priorityDate 2014-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73425380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087

Total number of triples: 30.